BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
-29 %
Last period Operating margin
What is Operating margin ?
Operating margin is the percentage of revenue a company retains after incurred production and operating costs, but before paying interest and taxes.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Operating margin is the percentage of revenue a company retains after incurred production and operating costs, but before paying interest and taxes.
BioNexus Gene`s Operating margin for the last twelve months ended 2023-09-30 is -29 %
